Utility Of Rubrics From Homoeopathic Medical Repertory By Dr. Robin Murphy In The Management Of Acne Vulgaris (Grade I, II, III) Among Age Group Of 16-25 Years: An Experimental Non-Controlled Study

INTRODUCTION

Acne vulgaris commonly affects individuals aged 16 to 25, impacting their physical and psychological wellbeing. Homoeopathy offers a holistic approach and Dr. Robin Murphy’s repertory provides clinically useful rubrics for acne management. This study aims to evaluate the practical utility and effectiveness of these rubrics in managing Grade I, II and III acne through individualized remedy selection.The inflammatory lesions, namely papules, pustules, nodules and cysts, indicate the severity of the disease. The severity of the acne can be graded on clinical grounds as under

Grade I Mild Comedones, occasional papules

Grade II Moderate Comedones, many papules, few pustules.

Grade III Severe Predominantly pustules, nodules and abscesses.

Grade IV Cystic Mainly Cysts or abscesses, widespread scarring

Homoeopathic Medical Repertory, a modern alphabetical repertory is mainly based on ‘Repertory of the Homoeopathic Materia Medica by Dr. J.T. Kent and Repertory of Hering’s Guiding Symptoms of our Materia Medica by Dr. C.B. Kneer. remedies. Dr. Robin Murphy’s Homoeopathic Medical Repertory is a clinically oriented repertory that blends classical and modern perspectives, offering a practical framework for repertorization based on symptom totality. Despite its widespread use in clinical practice, there is limited research evidence evaluating the utility and effectiveness of rubrics from this repertory in managing acne vulgaris.

AIM AND OBJECTIVE

Primary Objective To study the utility of rubrics from Homeopathic Medical Repertory by Dr. Robin Murphy in Management of Acne Vulgaris Grade I II III among age group of 16  to 25 years.

Other objective

1 To study clinical presentation of Acne Vulgaris Grade I II III among age group of 16 to 25 years.

2 To compare the patient pretreatment score and posttreatment score for Acne Vulgaris Grade I II III on GAGS Scale among age group of 16 to 25 years.

METHODOLOGY

1. Type of study design An Experimental Noncontrolled Study.

2. SettingThe study will be conducted at the OPD of the institution.

3. Duration of the study 18 months

4. Method of selection of study subjects

Inclusion Criteria

1.Clinically diagnosed cases of Acne Vulgaris Grade I II III

2. Patients of age group 16 to 25 years.

3. Patients of All Genders.

Exclusion Criteria

1. Grade IV Acne Vulgaris.

2. All other variants of acne like Acne conglobate, Acne fulminans, Acne excoriee etc.

3. Patient with complications of Acne Vulgaris like scarring.

4. Patient taking any other local or tropical medications for Acne Vulgaris.

5. Lactating Women or Pregnant Women.

6. Suspected immuno compromised cases.

Subject withdrawal criteria

Patients who do not wish to continue the treatment.

2. Patients who do not follow up regularly.

3. Patient developing any Medical Emergency.

Specification of instruments and related measurements:

1. Homoeopathic Case Taking Proforma will be used in each case.

2. Outcome assessment tool Prevalidated GAGS Scale will be used.

Outcome assessment criteria

a Outcome will be assessed in terms of

Improved if grades of improvement are fair,good or excellent or  greater than or equal to 25 percentage

Not improved if grades of improvement are poor or worse or less than 25 percentage

b) Outcome Pre and Post treatment according to GAGS scale.

Improvement was graded according to the 5 point Global Assessment Scale (GAS).

Grades of improvement by reduction in 5 point global assessment scale (GAS)

1.     Excellent  greater than or equal to 75 percentage improvement in GAS

2.     Good  50 percentage to 74 percentage improvement in GAS

3.     Fair 25 percentage to 49 percentage improvement in GAS

4.     Poor less than 25 percentage improvement in GAS

5.     Worse  Result worse than pre treatment finding.

Sample size 34 patients will be selected.

Sampling technique Nonprobablity Purposive sampling based on inclusion and exclusion criteria

Data management and analysis procedure

1.      Duration of study 18 months

2.     Duration of each  case  Each case will be studiedd upto 6 months or till recovery occurs, whichever is earlier.

3.     Duration of follow up ease case 15 days and earlier if required.

Clinical outcome assessment will be done at baseline of 1 month, 3 months and 6 months